Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Viral Hepatitis Society | OTHER |
Not provided
Not provided
Not provided
This study is a retrospective study conducted at 36 sites. Planned target patient number is 1000.
Approximately 36 centers will be included in Turkey. Centers will be selected from clinics of infection and clinical microbiology. The inclusion of 1000 patients was targeted. All data will be retrospectively collected from the medical records of the patients. Patient visit is not necessary.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Direct Acting Agents | No Intervention |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Disease management with direct acting agents | To assess disease management of chronic hepatitis C patients using direct acting agents (DAA) at national level, especially change in HCVRNA levels 12 weeks after the 24 weeks treatment (SVR12) | Beginning of treatment - 12 weeks after the treatment ended (36 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Treatment-Emergent Adverse Events | Adverse event list according to CTCAE v.4.03 | Up to 48 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients diagnosed as Hepatitis C and used direct acting agents.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fehmi Tabak, Prof | Viral Hepatitis Society | Principal Investigator |
| Tansu Yamazhan, Prof | Viral Hepatitis Society | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cerrahpasa Medical Faculty | Istanbul | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40384539 | Derived | Dirican E, Bal T, Onlen Y, Sarigul F, User U, Sari ND, Kurtaran B, Senates E, Gunduz A, Zerdali E, Karsen H, Batirel A, Karaali R, Guner HR, Yamazhan T, Kose S, Erben N, Ince NK, Koksal I, Oztoprak N, Yoruk G, Komur S, Kaya SY, Bozkurt I, Gunal O, Yildiz IE, Inan D, Barut S, Namiduru M, Tosun S, Turker K, Sener A, Hizel K, Baykam N, Duygu F, Bodur H, Can G, Gul HC, Tartar AS, Celebi G, Sunnetcioglu M, Karabay O, Kumbasar Karaosmanoglu H, Sirmatel F, Tabak OF. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach. J Clin Lab Anal. 2025 Jun;39(12):e70054. doi: 10.1002/jcla.70054. Epub 2025 May 19. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006526 | Hepatitis C |
| D006505 | Hepatitis |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D006525 | Hepatitis, Viral, Human |
Not provided
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |